Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: An Overview.

Struct Heart · 2022 · PMC10242582 · PMID 37288058

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

85 Analysis of data from the Vienna Registry (VIenna CardioThOracic Aortic Valve RegistrY trial) showed a trend toward improved 3-year survival in patients on non-VKA OACs compared to those on a VKA regimen. 86 Additionally, a recent study involving over 21,000 patients enrolled in the STS/ACC Transcatheter Valve Therapy Registry registry showed that in patients post-TAVR with AF, DOAC use has a comparable s

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.